Background: Luteolin has been demonstrated to possess numerous biological effects. However, the effect of luteolin on LPS (Lipopolysaccharides) stimulation in CPEK cells has not been investigated. Hypothesis/Objectives: An in vitro model of atopic canine dermatitis was used to identify the antioxidant effect of luteolin as a new treatment that is capable of improving the conditions of veterinary patients. Methods: CPEK cells were treated with or without luteolin in the presence or absence of LPS. A cell viability assay was performed to test luteolin toxicity and the protective effect of luteolin after LPS stimulation. Additionally, enzyme-linked immunosorbent assay (ELISA) kits were used to detect the levels of IL-33, IL-1β, IL-6, and IL-8. Results: Luteolin was capable to significantly decrease levels expression of IL-33, IL 1β, IL-6, and IL-8. Conclusions and clinical importance: Luteolin could be a new pharmacological treatment for canine atopic dermatitis.

Canine atopic dermatitis: role of luteolin as new natural treatment

Gugliandolo, Enrico
Primo
;
Cordaro, Marika;D’Amico, Ramona;Peritore, Alessio Filippo;Licata, Patrizia
Penultimo
;
Crupi, Rosalia
Ultimo
2020-01-01

Abstract

Background: Luteolin has been demonstrated to possess numerous biological effects. However, the effect of luteolin on LPS (Lipopolysaccharides) stimulation in CPEK cells has not been investigated. Hypothesis/Objectives: An in vitro model of atopic canine dermatitis was used to identify the antioxidant effect of luteolin as a new treatment that is capable of improving the conditions of veterinary patients. Methods: CPEK cells were treated with or without luteolin in the presence or absence of LPS. A cell viability assay was performed to test luteolin toxicity and the protective effect of luteolin after LPS stimulation. Additionally, enzyme-linked immunosorbent assay (ELISA) kits were used to detect the levels of IL-33, IL-1β, IL-6, and IL-8. Results: Luteolin was capable to significantly decrease levels expression of IL-33, IL 1β, IL-6, and IL-8. Conclusions and clinical importance: Luteolin could be a new pharmacological treatment for canine atopic dermatitis.
2020
File in questo prodotto:
File Dimensione Formato  
Veterinary Medicine Sci - 2020 - Gugliandolo - Canine atopic dermatitis Role of luteolin as new natural treatment.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 558.45 kB
Formato Adobe PDF
558.45 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3172173
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact